Micron Technology R&D increased by 6.7% to $1.25B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 39.2%, from $898.00M to $1.25B. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 9.3% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $670.00M | $705.00M | $712.00M | $792.00M | $773.00M | $839.00M | $849.00M | $788.00M | $758.00M | $719.00M | $845.00M | $832.00M | $850.00M | $903.00M | $888.00M | $898.00M | $965.00M | $1.05B | $1.17B | $1.25B |
| QoQ Change | — | +5.2% | +1.0% | +11.2% | -2.4% | +8.5% | +1.2% | -7.2% | -3.8% | -5.1% | +17.5% | -1.5% | +2.2% | +6.2% | -1.7% | +1.1% | +7.5% | +8.5% | +11.8% | +6.7% |
| YoY Change | — | — | — | — | +15.4% | +19.0% | +19.2% | -0.5% | -1.9% | -14.3% | -0.5% | +5.6% | +12.1% | +25.6% | +5.1% | +7.9% | +13.5% | +15.9% | +31.9% | +39.2% |